Eligibility Criteria May Influence Disparity in MM Trial Enrollment
Eligibility criteria may contribute to racial and ethnic disparities in enrollment in MM trials supporting drug approvals.
Eligibility criteria may contribute to racial and ethnic disparities in enrollment in MM trials supporting drug approvals.
New research suggests that carfilzomib increases the risk of heart failure in patients with multiple myeloma, but the risk does not appear to vary between Black and White patients.
A recent study revealed a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
For adults with a history of cancer, delayed care due to lack of transportation is associated with increased ER use and all-cause mortality, a study suggests.
Cancer survivors may be more likely to delay or forgo care if their treating clinician is of a different race, gender, or other identity, a new study suggests.
Patients with MCC may have different sites of disease, stage at diagnosis, and survival outcomes according to their racial or ethnic group.
Though mortality rates for uterine cancer are on the rise, research for this cancer is underfunded, a study suggests.
A larger proportion of patients with private or Medicare insurance received a diagnosis of early-stage cervical cancer.
TNBC incidence rates ranged from less than 7 per 100,000 among Asian and Pacific Islander patients to more than 29 per 100,000 among Black patients.
Living along the Texas-Mexico border is associated with worse survival in children diagnosed with acute lymphoblastic leukemia.